SERPINE1 levels have been identified to be significantly increased in colorectal cancer [50], lung cancer [51], gastric cancer [52], bladder cancer [53], head and neck squamous cell carcinoma [54], and others. This evidence concerns the gene SERPINE1 and lung carcinoma.